API Solutions

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries.

R&D

Dr. Reddy’s supplies generic APIs to 80+ countries, excelling in R\&D across niche molecules and key therapies, with capabilities from lab to production in contained/non-contained APIs and advanced chemical processes.

White Paper

Dr. Reddy’s offers insightful whitepapers sharing expertise on APIs, formulations, regulatory trends, and industry innovations, helping global pharma partners gain knowledge, solve challenges, and drive faster, compliant product development.

Dr. Reddys API Team at CPHI Japan 2026

Dr. Reddy’s API team participated in CPHI Japan 2026, held at Tokyo Big Sight, engaging with global pharmaceutical stakeholders across the ingredients and manufacturing value chain. CPHI Japan is widely recognised as a key platform connecting international suppliers with the highly regulated Japanese and Asia‑Pacific markets.

During the event, the team interacted with customers and partners to discuss complex APIs, advanced manufacturing processes, quality, and regulatory expectations, reflecting the evolving needs of global pharma supply chains. Japan’s strong focus on quality and compliance made the event particularly relevant for discussions around long‑term partnerships and sustainable sourcing. Participation at CPHI Japan 2026 reaffirmed Dr. Reddy’s commitment to delivering reliable, compliant, and scalable API solutions to customers worldwide.

View More News